Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies. Li BT, Gandhi L, Ravichandran V, Besse B, et al. Clin Lung Cancer 2026;27:214-226.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li BT, Gandhi L, Ravichandran V, Besse B, et al. Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies. Clin Lung Cancer 2026;27:214-226.
PMID: 41193346